Results 251 to 260 of about 9,997,733 (366)
Orbital inflammatory disease: Pictorial review and differential diagnosis
Michael N Pakdaman
openalex +1 more source
An Ultra‐Selective and Humidity‐Resistant Room‐Temperature‐Operated NO2 Sensor Based on Black TiO2
A room‐temperature‐operated NO2 sensor that achieves ultrahigh selectivity and humidity resistance is developed using black TiO2 for the first time in this work. A portable sensing equipment capable of recognizing NO2 from a mixed atmosphere with several common interfering gases and identifying real environmental differences is developed ...
Xuelan Cheng +10 more
wiley +1 more source
A novel nomogram based on orbital MRI parameters for early prediction of dysthyroid optic neuropathy in thyroid-associated ophthalmopathy. [PDF]
Zhao X, Li Y, Lu Y, Liu M, Li Z.
europepmc +1 more source
Orbital compression syndrome in sickle cell disease
Mada Yateem +4 more
openalex +1 more source
The model shows the probiotics screening and underlying mechanisms of F. rodentiumn in alleviating IR‐induced tissue injury. Stress‐induced STAT3 mitochondria localization decreases F. rodentium abundance and butyrate concentration. Supplementation of F.
Hanyong Zhu +17 more
wiley +1 more source
Ophthalmic Complications After Dental Procedures: Scoping Review. [PDF]
Wang XC, Zhao C, Wu KY, Marchand M.
europepmc +1 more source
This study establishes a mandibular asymmetry (MA) mouse model that recapitulates chronic orofacial pain and anxiety comorbidity. Anterior cingulate cortex (ACC) hyperactivation and synaptic dysfunction are identified as central neural mechanisms underlying these pathologies, with chemogenetic inhibition of ACC CaMKII+ neurons effectively reversing ...
Zhaoyichun Zhang +19 more
wiley +1 more source
Efficacy and safety analysis of endoscopic navigation-guided 3D printing technology combined with absorbable materials in the treatment of orbital blowout fractures. [PDF]
Ren Z +7 more
europepmc +1 more source
This study presents an engineered probiotic platform, iRGD‐mRBC@FOLactis, combining red blood cell membrane cloaking and tumor‐penetrating peptide iRGD for enhanced PD‐1 blockade. The platform improves tumor targeting, immune cell activation and therapeutic efficacy in lung cancer, demonstrating significant promise in overcoming PD‐1/PD‐L1 therapy ...
Chen Chen +9 more
wiley +1 more source

